Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06004232 · ClinicalTrials.gov registry record · NA

Prenatal Yoga to Prevent Postpartum Depression

A NA study of Postpartum Depression, sponsored by Henry Ford Health System.

Active
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT06004232 is a NA study of Postpartum Depression that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 62 participants, below the 533-participant average among 38 other Postpartum Depression trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06004232, a NA study of Postpartum Depression, is active but no longer recruiting, sponsored by Henry Ford Health System.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

Although psychological interventions exist for the prevention of PPD, a yoga-based intervention to prevent PPD among at-risk women utilizes a similar theoretical foundation (i.e., mindfulness), may be more acceptable to women of minority status, and may confer additional physical activity benefits. The purpose of this pilot study is to determine the effectiveness of using a virtually delivered prenatal yoga intervention for the prevention of PPD among at-risk women in a diverse health care system and explore preliminary factors which influence implementation of the intervention. This study has 2 phases: Phase 1 will evaluate facilitators and barriers to intervention implementation among patient, clinician, and health system stakeholders, followed by an open trial, and Phase 2 will include conducting an 8-session pilot randomized controlled trial to assess the feasibility and acceptability of the proposed prenatal yoga intervention among women with a history of depression, as well as the onset and course of PPD and mediating factors. The specific aims are to: 1) Optimize delivery of a yoga intervention within a healthcare system to prevent PPD through examining facilitators and barriers of implementation, 2) Examine feasibility, acceptability and satisfaction of the intervention within a health care system, and 3) Evaluate preliminary effectiveness of the intervention on PPD and proposed mechanisms. For Phase 1, separate focus groups with patient stakeholders and clinician and administrative stakeholders will inform intervention implementation, and an open trial to refine and optimize the intervention. For Phase 2, women with a history of depression who are 8-28 weeks pregnant will be randomized to the intervention group (n=24) or treatment-as-usual (n=24) and will complete survey measures at baseline, post-intervention, and 1 and 3 months postpartum. It is hypothesized that the intervention will be feasible and acceptable, engage women of racial/ethnic minority stat

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as Usual (TAU)
  • BEHAVIORAL Prenatal Yoga to Prevent Postpartum Depression (PRY-D) intervention

Study Locations (1)

Michigan

  • Henry Ford Health - Detroit

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2025-02-26
Est. Completion 2026-03
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT06004232

The ClinicalTrials.gov registry entry for NCT06004232 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 533-participant average among 38 other Postpartum Depression trials with a reported enrollment target (88% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT06004232 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06004232 about?

NCT06004232 is a clinical study titled "Prenatal Yoga to Prevent Postpartum Depression". Although psychological interventions exist for the prevention of PPD, a yoga-based intervention to prevent PPD among at-risk women utilizes a similar theoretical foundation (i.e., mindfulness), may be more acceptable to women of minority status, and may confer additional physical activity benefits. ...

What is the current status of trial NCT06004232?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2025-02-26. Estimated completion is 2026-03.

What conditions does trial NCT06004232 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT06004232?

The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Prenatal Yoga to Prevent Postpartum Depression (PRY-D) intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06004232?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06004232 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.